Home Cart 0 Sign in  
X

[ CAS No. 133831-28-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 133831-28-4
Chemical Structure| 133831-28-4
Chemical Structure| 133831-28-4
Structure of 133831-28-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 133831-28-4 ]

Related Doc. of [ 133831-28-4 ]

Alternatived Products of [ 133831-28-4 ]

Product Details of [ 133831-28-4 ]

CAS No. :133831-28-4 MDL No. :MFCD00216479
Formula : C11H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :KRDRROJESQUFMJ-UHFFFAOYSA-N
M.W : 203.19 Pubchem ID :735867
Synonyms :

Calculated chemistry of [ 133831-28-4 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.09
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 54.97
TPSA : 59.16 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.57 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.48
Log Po/w (XLOGP3) : 1.36
Log Po/w (WLOGP) : 1.77
Log Po/w (MLOGP) : 0.74
Log Po/w (SILICOS-IT) : 2.52
Consensus Log Po/w : 1.57

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.2
Solubility : 1.27 mg/ml ; 0.00627 mol/l
Class : Soluble
Log S (Ali) : -2.2
Solubility : 1.27 mg/ml ; 0.00624 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.31
Solubility : 0.0986 mg/ml ; 0.000485 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.48

Safety of [ 133831-28-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 133831-28-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 133831-28-4 ]
  • Downstream synthetic route of [ 133831-28-4 ]

[ 133831-28-4 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 133831-28-4 ]
  • [ 184151-49-3 ]
YieldReaction ConditionsOperation in experiment
49.58% With borane-THF In tetrahydrofuran at 50℃; for 1 h; Inert atmosphere To a stirred solution of compound 27 (0.78 g, 3.84 mmol) in dry THF (30 mL) at°C under argon atmosphere, borane in THF (1M, 15.36 mL, 15.36 mmol) was added drop wise. The resulting reaction mass was stirred at 50 °C for 1 h. The progress of the reaction was monitored by TLC. After completion, the reaction mixture was quenched with sat. NH4C1 solution (50 mL) and extracted with ethyl acetate (3 X 50 mL). The combined organic layerswere dried over anhydrous sodium sulfate, filtered and concentrated in vacuo to obtain theThe crude compound was purified by silica gel column chromatography using 10percentEtOAc/hexane to afford compound 28 (0.36 g, 49.5 8percent) as a brown solid. TLC: 30percentEtOAc/Hexane (Rf: 0.6); ‘H-NMR (400 MHz, DMSO-d6): ö 11.15 (s, 1H), 8.00 (s, 1H), 7.627.55 (m, 2H), 7.37 (s, 1H), 3.84 (s, 3H), 3.27 (s, 3H), LCMS Observed (m/z): 189.90 (M+1).
Reference: [1] Chemistry - A European Journal, 2016, vol. 22, # 37, p. 13004 - 13009
[2] Patent: WO2018/53157, 2018, A1, . Location in patent: Page/Page column 158
[3] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 14, p. 1867 - 1872
[4] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 21, p. 3053 - 3058
[5] Patent: WO2006/100036, 2006, A1, . Location in patent: Page/Page column 159-160
  • 2
  • [ 110-01-0 ]
  • [ 1576-35-8 ]
  • [ 133831-28-4 ]
  • [ 184151-49-3 ]
Reference: [1] Patent: US6303600, 2001, B1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 133831-28-4 ]

Aldehydes

Chemical Structure| 312973-24-3

[ 312973-24-3 ]

Methyl 3-formyl-1H-indole-7-carboxylate

Similarity: 0.96

Chemical Structure| 467458-46-4

[ 467458-46-4 ]

Ethyl 3-formyl-1H-indole-5-carboxylate

Similarity: 0.96

Chemical Structure| 881179-23-3

[ 881179-23-3 ]

Ethyl 3-formyl-1H-indole-4-carboxylate

Similarity: 0.96

Chemical Structure| 927181-97-3

[ 927181-97-3 ]

Ethyl 3-formyl-1H-indole-6-carboxylate

Similarity: 0.96

Chemical Structure| 1071973-79-9

[ 1071973-79-9 ]

Benzyl 3-formyl-1H-indole-5-carboxylate

Similarity: 0.96

Esters

Chemical Structure| 227960-12-5

[ 227960-12-5 ]

Methyl 5-methylindole-3-carboxylate

Similarity: 0.98

Chemical Structure| 942-24-5

[ 942-24-5 ]

Methyl indole-3-carboxylate

Similarity: 0.98

Chemical Structure| 184151-49-3

[ 184151-49-3 ]

Methyl 3-methyl-1H-indole-6-carboxylate

Similarity: 0.98

Chemical Structure| 588688-33-9

[ 588688-33-9 ]

Methyl 3-methyl-1H-indole-5-carboxylate

Similarity: 0.98

Chemical Structure| 1071973-79-9

[ 1071973-79-9 ]

Benzyl 3-formyl-1H-indole-5-carboxylate

Similarity: 0.96

Related Parent Nucleus of
[ 133831-28-4 ]

Indoles

Chemical Structure| 227960-12-5

[ 227960-12-5 ]

Methyl 5-methylindole-3-carboxylate

Similarity: 0.98

Chemical Structure| 942-24-5

[ 942-24-5 ]

Methyl indole-3-carboxylate

Similarity: 0.98

Chemical Structure| 184151-49-3

[ 184151-49-3 ]

Methyl 3-methyl-1H-indole-6-carboxylate

Similarity: 0.98

Chemical Structure| 588688-33-9

[ 588688-33-9 ]

Methyl 3-methyl-1H-indole-5-carboxylate

Similarity: 0.98

Chemical Structure| 881179-23-3

[ 881179-23-3 ]

Ethyl 3-formyl-1H-indole-4-carboxylate

Similarity: 0.96